Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,286 public trials 1,280 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

NCT03897881

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • California Pacific Medical Center Research Institute -CPMCRI San Francisco, California, United States
  • Angeles Clinic and Research Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

NCT02743741

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Sunnybrook Odette Cancer Center Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

LAM561 With RT and TMZ for Adults With Glioblastoma

NCT04250922

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations
  • Institut Cancerologie de L'Ouest (ICO) Angers, France
  • Centre Eugène Marquis (CEM) Rennes, France
  • Gustave Roussy University Hospital Rennes, France
  • Institut universitaire du cancer Toulouse, France
View all 22 locations
View Trial Details

Related conditions